Thinking of joining a study?

Register your interest

NCT04889326 | RECRUITING | Covid19


Collection of the Thrombo-VaxCov Cohort
Sponsor:

University Hospital, Lille

Brief Summary:

In the context of anti-Covid19 vaccination, atypical thrombosis have occured and potential link with vaccination is under investigation. This study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after antiCovid vaccination.

Condition or disease

Covid19

SARS-CoV Infection

Venous Thrombosis

Thrombocytopenia

Vaccination; Complications

Intervention/treatment

Retrospective data and biological samples

Detailed Description:

In the context of anti-Covid19 vaccination, atypical thrombosis have occurred and potential links with vaccination is under investigation. In France, the study collect clinical and biological data of all atypical thrombosis occurring within 4 weeks after anti-Covid vaccination.

Study Type : OBSERVATIONAL
Estimated Enrollment : 100 participants
Official Title : A Clinico-biological Database on Atypical Venous Thrombosis in the Context of anticovid19 Vaccination
Actual Study Start Date : 2021-04-02
Estimated Primary Completion Date : 2023-05
Estimated Study Completion Date : 2023-05

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • atypical thrombosis symptoms onset within 4 weeks of vaccination
Exclusion Criteria
  • children

Collection of the Thrombo-VaxCov Cohort

Location Details

NCT04889326


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

France,

CHU lille

Lille, France, 59037

Loading...